北京中医药行业治理整顿见效,平均住院费首现负增长

2017-03-19 崔芳 健康报

门诊患者次均费用涨幅下降,住院患者例均费用首次出现负增长。3月17日在京召开的2017年北京中医医政工作会公布的数据提示,该市去年开展的行业治理整顿效果突出。据悉,北京市为了控制中医药诊疗费用不合理增长,去年祭出“组合拳”。一是开展并完成14家大型中医医院巡查工作,通过巡查促使医院提升管理水平,促进医院自我管理、自我约束、自我发展。二是开展中药饮片应用规范化管理质控,“合理检查、合理治疗、合理用药

门诊患者次均费用涨幅下降,住院患者例均费用首次出现负增长。3月17日在京召开的2017年北京中医医政工作会公布的数据提示,该市去年开展的行业治理整顿效果突出。

据悉,北京市为了控制中医药诊疗费用不合理增长,去年祭出“组合拳”。一是开展并完成14家大型中医医院巡查工作,通过巡查促使医院提升管理水平,促进医院自我管理、自我约束、自我发展。二是开展中药饮片应用规范化管理质控,“合理检查、合理治疗、合理用药”三合理等专项行动,通过业务培训、单位自查、飞行检查、专项评估等方式,指导各中医机构完善、落实制度、持续改进。三是启动中药饮片处方点评工作,试点开展中医医院中药饮片处方“双限”(即限制单个处方的药味数、限制处方贴均费用)管理,建立中药饮片处方质量指标监测平台。四是推进中医药行业自律机制建设,成立北京中医药行业自律工作委员会,组织开展疑难案例讨论,推进行业规则建设等。

上述举措的实施取得成效,据统计,2016年,北京市中医类医院患者门诊次均费用415.3元,比全市医院门诊次均费用低44.8元,比2015年增长5.17%,涨幅下降了3.58个百分点。住院患者例均医疗费用16589.1元,比全市医院住院例均费用低4038.5元,比2015年下降了0.880%,首次出现了负增长。

会上,北京市中医管理局相关负责人透露,2017年,该市还将组织实施中医药“降费、提效、优服”专项行动,提出中医药控费指标和措施,提升中医药服务效果、效率、效益,优化中医药服务环境和服务流程的措施,着力为患者提供更为优质、实惠的中医药服务。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1408858, encodeId=093b1408858a4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593864, encodeId=3c431593864b9, content=<a href='/topic/show?id=15c95e85376' target=_blank style='color:#2F92EE;'>#整顿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57853, encryptionId=15c95e85376, topicName=整顿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa118174016, createdName=liuxiaona, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604958, encodeId=2f9d1604958b2, content=<a href='/topic/show?id=a631353e6e6' target=_blank style='color:#2F92EE;'>#医药行业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35376, encryptionId=a631353e6e6, topicName=医药行业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbd19305036, createdName=fmq_28614559, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181492, encodeId=797b181492f2, content=这种现象正常吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/19/68358be9323aa8e32edd53bfd17742f1.jpg, createdBy=5a191960665, createdName=1e135751m36(暂无匿称), createdTime=Mon Mar 20 21:35:04 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181364, encodeId=827e181364c6, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 20 09:56:40 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181268, encodeId=14dd18126813, content=都是忽悠人的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Mar 20 00:05:43 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
    2017-03-21 cathymary
  2. [GetPortalCommentsPageByObjectIdResponse(id=1408858, encodeId=093b1408858a4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593864, encodeId=3c431593864b9, content=<a href='/topic/show?id=15c95e85376' target=_blank style='color:#2F92EE;'>#整顿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57853, encryptionId=15c95e85376, topicName=整顿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa118174016, createdName=liuxiaona, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604958, encodeId=2f9d1604958b2, content=<a href='/topic/show?id=a631353e6e6' target=_blank style='color:#2F92EE;'>#医药行业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35376, encryptionId=a631353e6e6, topicName=医药行业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbd19305036, createdName=fmq_28614559, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181492, encodeId=797b181492f2, content=这种现象正常吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/19/68358be9323aa8e32edd53bfd17742f1.jpg, createdBy=5a191960665, createdName=1e135751m36(暂无匿称), createdTime=Mon Mar 20 21:35:04 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181364, encodeId=827e181364c6, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 20 09:56:40 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181268, encodeId=14dd18126813, content=都是忽悠人的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Mar 20 00:05:43 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
    2017-03-21 liuxiaona
  3. [GetPortalCommentsPageByObjectIdResponse(id=1408858, encodeId=093b1408858a4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593864, encodeId=3c431593864b9, content=<a href='/topic/show?id=15c95e85376' target=_blank style='color:#2F92EE;'>#整顿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57853, encryptionId=15c95e85376, topicName=整顿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa118174016, createdName=liuxiaona, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604958, encodeId=2f9d1604958b2, content=<a href='/topic/show?id=a631353e6e6' target=_blank style='color:#2F92EE;'>#医药行业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35376, encryptionId=a631353e6e6, topicName=医药行业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbd19305036, createdName=fmq_28614559, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181492, encodeId=797b181492f2, content=这种现象正常吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/19/68358be9323aa8e32edd53bfd17742f1.jpg, createdBy=5a191960665, createdName=1e135751m36(暂无匿称), createdTime=Mon Mar 20 21:35:04 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181364, encodeId=827e181364c6, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 20 09:56:40 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181268, encodeId=14dd18126813, content=都是忽悠人的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Mar 20 00:05:43 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1408858, encodeId=093b1408858a4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593864, encodeId=3c431593864b9, content=<a href='/topic/show?id=15c95e85376' target=_blank style='color:#2F92EE;'>#整顿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57853, encryptionId=15c95e85376, topicName=整顿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa118174016, createdName=liuxiaona, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604958, encodeId=2f9d1604958b2, content=<a href='/topic/show?id=a631353e6e6' target=_blank style='color:#2F92EE;'>#医药行业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35376, encryptionId=a631353e6e6, topicName=医药行业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbd19305036, createdName=fmq_28614559, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181492, encodeId=797b181492f2, content=这种现象正常吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/19/68358be9323aa8e32edd53bfd17742f1.jpg, createdBy=5a191960665, createdName=1e135751m36(暂无匿称), createdTime=Mon Mar 20 21:35:04 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181364, encodeId=827e181364c6, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 20 09:56:40 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181268, encodeId=14dd18126813, content=都是忽悠人的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Mar 20 00:05:43 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
    2017-03-20 1e135751m36(暂无匿称)

    这种现象正常吗?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1408858, encodeId=093b1408858a4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593864, encodeId=3c431593864b9, content=<a href='/topic/show?id=15c95e85376' target=_blank style='color:#2F92EE;'>#整顿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57853, encryptionId=15c95e85376, topicName=整顿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa118174016, createdName=liuxiaona, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604958, encodeId=2f9d1604958b2, content=<a href='/topic/show?id=a631353e6e6' target=_blank style='color:#2F92EE;'>#医药行业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35376, encryptionId=a631353e6e6, topicName=医药行业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbd19305036, createdName=fmq_28614559, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181492, encodeId=797b181492f2, content=这种现象正常吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/19/68358be9323aa8e32edd53bfd17742f1.jpg, createdBy=5a191960665, createdName=1e135751m36(暂无匿称), createdTime=Mon Mar 20 21:35:04 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181364, encodeId=827e181364c6, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 20 09:56:40 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181268, encodeId=14dd18126813, content=都是忽悠人的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Mar 20 00:05:43 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
    2017-03-20 Chongyang Zhang

    签到学习了很多。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1408858, encodeId=093b1408858a4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593864, encodeId=3c431593864b9, content=<a href='/topic/show?id=15c95e85376' target=_blank style='color:#2F92EE;'>#整顿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57853, encryptionId=15c95e85376, topicName=整顿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa118174016, createdName=liuxiaona, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604958, encodeId=2f9d1604958b2, content=<a href='/topic/show?id=a631353e6e6' target=_blank style='color:#2F92EE;'>#医药行业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35376, encryptionId=a631353e6e6, topicName=医药行业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbd19305036, createdName=fmq_28614559, createdTime=Tue Mar 21 12:06:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181492, encodeId=797b181492f2, content=这种现象正常吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/03/19/68358be9323aa8e32edd53bfd17742f1.jpg, createdBy=5a191960665, createdName=1e135751m36(暂无匿称), createdTime=Mon Mar 20 21:35:04 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181364, encodeId=827e181364c6, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 20 09:56:40 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=181268, encodeId=14dd18126813, content=都是忽悠人的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Mar 20 00:05:43 CST 2017, time=2017-03-20, status=1, ipAttribution=)]
    2017-03-20 飛歌

    都是忽悠人的

    0

相关资讯

我去“北京雾霾源头”呆了三天

雾霾来了,戴口罩是最简单直接的防护方式,但是有很多人其实并不知道戴口罩也有讲究,错误的戴法其实起不到防护作用。北京市疾控中心也拍摄了一组正确戴口罩的组图,由医务人员来教你如何正确戴口罩。

北京:医院自主定价来了

从明年1月1日起,公立医疗机构开展的特需医疗服务、新增医疗服务和部分医疗服务项目价格,将执行医院自主定价。据悉,这是北京市医疗服务价格改革的第二步。此前北京已调整院前急救服务项目价格,今年年底或明年年初将按照国家医疗服务价格项目规范,启动首批医疗服务价格调整。北京市卫生计生委副主任钟东波说,按照北京市发展改革委的计划,今年北京市医疗服务价格改革分三步走,最终将探索建立可动态调整、分类管理的价格

疾控中心:红色预警来了,口罩如何选择与佩戴?

北京市空气重污染应急指挥部发布空气重污染红色预警:12月16日20时至21日国Ⅰ国Ⅱ排放标准机动车禁止上路行驶,国Ⅲ及以上机动车单双号行驶;企事业单位可根据情况错峰上下班、调休或远程办公,中小学幼儿园采取弹性教学或停课等防护措施。1、口罩的主要分类和标准市场上的口罩主要分工业用、医用和民用。工业用口罩执行GB2626-2006《呼吸防护用品自吸过滤式防颗粒物呼吸器》标准,医用防护口罩执行GB190

北京已确诊4例输入性黄热病病例

北京市卫生计生委今日(3月21日)通报,昨天新确诊1例输入性黄热病病例,这是继3月13日北京发现中国首例输入性黄热病病例后,确诊的第4例病例。 据通报,患者张某,男,50岁,福建省三明市人,安哥拉务工人员,出国前未接种黄热病疫苗。患者于3月6日(北京时间)在安哥拉出现发热、全身不适等症状,3月6日至16日前往当地多家医院诊治,3月18日乘飞机经迪拜转机,3月18日晚抵达北京首都机场,入境时体温正

辟谣:北京肺癌暴增43%是断章取义!

当在室内40分钟吸第三支烟的时候,室内PM2.5超过1600微克/立方米,远远高出室外PM2.5的浓度,可见吸烟产生的PM2.5的危害从致癌物种类和有害物质浓度都要远远高于雾霾的PM2.5含量。   最近网上疯传北京市肺癌的发病率约增长了43%,该信息来源于2014年6月北京市人民政府发布的《北京市2013年度卫生与人群健康状况报告》第12页1.2.1肺癌章节“肺癌发病率由20

未来五年,在北京看病的正确姿势是什么样

北京市“十三五”时期卫生计生事业发展规划26日正式发布,引起网友关注。被网友称为“全国看病中心”的北京,未来五年将如何实现优质医疗资源的均衡配置?随着药价和医事服务费用的放开,个人负担会不会上升?面对人口快速老龄化和全面放开“二孩”的压力,医疗服务质量怎么提升?记者采访北京市卫计委负责人,带来权威解读。“看病堵”如何疏解?——遏制资源集中,探索区域协同 近两年的北京市诊疗人次数据显示